Pancreatic Cancer Research

ResearcherWake Forest University Health SciencesNo recent work listed

Edward Allen Levine

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7683-9502; OpenAlex author ID A5040292764. Sources: ClinicalTrials.gov.

Their work

Papers
1
Trials
1
Grants
0
Labs led
0
Collaborators
3
Papers, trials and grants by year

1999: 1 trial · 2000: none · 2001: none · 2002: none · 2003: none · 2004: none · 2005: none · 2006: none · 2007: none · 2008: none · 2009: none · 2010: none · 2011: none · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 1

  1. Optimal Adjuvant Treatment Approach After Upfront Resection of Pancreatic Cancer: Revisiting the Role of Radiation Based on Pathologic Features. Co-author DOI 10.1097/sla.0000000000003770↗

Trials 1

  1. Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder Study chair NCT00489515↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Clancy J. Clark · 1 shared paper, 2021 · strength 0.15
  2. Perry Shen · 1 shared paper, 2021 · strength 0.15
  3. Omeed Moaven · 1 shared paper, 2021 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.